Literature DB >> 1809048

Flumazenil antagonizes the suppressive effect of midazolam on the somatosensory evoked potentials in the rat.

N Suzuki1, Y Hirose, N Katakura, Y Kubota.   

Abstract

The effect of flumazenil, a specific benzodiazepine antagonist, on the midazolam-induced suppression of somatosensory evoked potentials (SEPs) following strong electrical stimulation of the upper lip was investigated in Wistar albino rats. The averaged SEPs were recorded from the contralateral surface of the skull in the temporal area. Each rat received midazolam in a dose of 10 mg/kg intraperitoneally. Five min after midazolam injection, the relative amplitude of the P1N1 wave of the SEPs was reduced significantly. A 0.5 mg dose of flumazenil or physiological saline was injected intraperitoneally 7.5 min after midazolam injection. The P1N1 amplitude recovered rapidly to the control value in the flumazenil group but not in the physiological saline group. No significant differences were found in the latencies of the P1 and N1 peaks before or after midazolam or flumazenil injection. It is suggested that flumazenil strongly antagonizes the midazolam-induced suppression of SEPs in the rat.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1809048      PMCID: PMC2162361     

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  9 in total

Review 1.  Pharmacology of Dormicum (midazolam) and Anexate (flumazenil).

Authors:  R Amrein; W Hetzel
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1990

2.  Flumazenil in the outpatient. A study following midazolam as sedation for upper gastrointestinal endoscopy.

Authors:  P J Andrews; D J Wright; M C Lamont
Journal:  Anaesthesia       Date:  1990-06       Impact factor: 6.955

3.  Effects of electroacupuncture on the somatosensory evoked response in rat.

Authors:  K Toda; M Ichioka; H Suda; A Iriki
Journal:  Exp Neurol       Date:  1979-03       Impact factor: 5.330

4.  Effects of diazepam (cercine) on the somatosensory evoked responses following tooth pulp stimulation in rat.

Authors:  K Toda; H Tanaka; A Iriki
Journal:  Bull Tokyo Med Dent Univ       Date:  1979-06

5.  The use of flumazenil (Anexate, Ro 15-1788) in the management of drug overdose.

Authors:  B J Pollard; A P Masters; P Bunting
Journal:  Anaesthesia       Date:  1989-02       Impact factor: 6.955

6.  Benzodiazepine intoxication treated with flumazenil (Anexate, RO 15-1788).

Authors:  L Knudsen; L Lonka; B H Sørensen; L Kirkegaard; O V Jensen; S Jensen
Journal:  Anaesthesia       Date:  1988-04       Impact factor: 6.955

7.  Midazolam and somatosensory evoked potentials.

Authors:  N Suzuki; S Beppu; H Uematsu; T Someya; Y Kubota
Journal:  Anesth Prog       Date:  1985 Sep-Oct

8.  Flumazenil used for antagonizing the central effects of midazolam and diazepam in outpatients.

Authors:  S Jensen; L Knudsen; L Kirkegaard; A Kruse; E B Knudsen
Journal:  Acta Anaesthesiol Scand       Date:  1989-01       Impact factor: 2.105

9.  Recovery from fixed-dose midazolam-induced anaesthesia and antagonism with flumazenil for outpatient arthroscopy.

Authors:  W W Zuurmond; L van Leeuwen; J H Helmers
Journal:  Acta Anaesthesiol Scand       Date:  1989-02       Impact factor: 2.105

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.